Read This Journal
View Current Issue (Volume 100 Issue 13 July 2, 2008)
Advance Access
Browse the archive
Browse by subject
Highlights
LISTEN to JNCI Podcast: Issue 13 Summary- Imatinib Resistance in Leukemia Patients Linked to LYN Kinase Activation
Activation of LYN kinase is associated with resistance to imatinib in patients with chronic myelogenous leukemia.
FREE: Persistent LYN Signaling in Imatinib-Resistant, BCR-ABL–Independent
Chronic Myelogenous Leukemia
- NSAID Use Not Associated With Melanoma Risk
Nonsteroidal anti-inflammatory drugs (NSAIDs) do not appear to be good candidates for melanoma chemoprevention, as no association was found between NSAID use and melanoma risk. - Neuroblastoma Tumor Suppressor Gene Identified
CHD5 is a tumor suppressor gene and is associated with survival outcome in neuroblastoma patients.
